MicroPort CRM has received approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its new range of Alizea pacemakers equipped with Bluetooth technology.
The new implantable pacemakers are paired with the company’s SmartView Connect home monitor, which helps to streamline remote monitoring.
The home monitor system provides cardiologists with detailed patient reports and timely alerts, as well as offering advanced remote monitoring and follow-up.
It can be placed at the patient’s bedside for regular transmission of detailed patient reports regarding the functioning of the pacing system.
The device reduces the burden on the healthcare system and eliminates the need for patients to visit the hospital for routine check-ups.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataSee Also:
Together, the Alizea pacemakers and the SmartView Connect home monitor provide cardiologists with timely alerts of a patient’s clinical status.
This helps in providing quicker and more efficient patient care.
MicroPort CRM Sales Japan vice-president Noboru Shimizu said: “Around 64,000 patients are implanted with a pacemaker each year in Japan and, coupled with the difficulties that have arisen from the current health crisis, there is a growing need to monitor patients remotely, without them having to travel.
“Thanks to Alizea pacemakers and its SmartView Connect monitor, we are positioning ourselves in the Japanese market with the very best in cardiac pacing. I am convinced that this will allow us to strengthen our presence in Japan.”
The latest Alizea pacemakers include AutoMRI, which helps to automatically protect patients when they undergo MRI scans.
A Sleep Apnea Monitoring (SAM) feature is also included in the latest generation of pacemakers. This can help to reveal under-diagnosed diseases with significant cardiac comorbidities, such as atrial fibrillation.
The pacemakers also feature SafeR, a pacing mode that is proven to prevent the first onset of atrial fibrillation by minimising unnecessary ventricular pacing.
Last October, German medical device manufacturer Hemovent was acquired by MicroPort Surgical, a critical care subsidiary of MicroPort Scientific.
